Brooke is an assistant editor for The American Journal of Managed Care® (AJMC®). She joined AJMC in 2023, where she produces written content covering multiple disease states.
She has a BA in journalism from Seton Hall University. You can connect with Brooke on LinkedIn.
VR-Based Pulmonary Rehabilitation More Effective in Patients With COPD, Study Says
January 21st 2024Virtual reality (VR) combined with pulmonary rehabilitation was more effective than pulmonary rehabilitation alone in improving the pulmonary function, exercise capacity, and mental health of patients with chronic obstructive pulmonary disease (COPD).
Gabapentinoid Use in COPD Associated With Increased Severe Exacerbation Risk, Study Says
January 15th 2024Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic pain, and other chronic pain.
High White Blood Cell Counts Are Associated With Long-Term Acute COPD Exacerbations, Study Says
January 13th 2024The study's findings suggest that high baseline white blood cell count, particularly high neutrophil count, was associated with a higher incidence of long-term acute exacerbation of chronic obstructive pulmonary disease (COPD).
Dr Sandra Stein Shares Takeaways From Banner|Aetna IVBM
January 13th 2024According to Sandra Stein, MD, of Banner Health Plans, the event highlighted the significant influence of social determinants of health on health care costs and outcomes, emphasizing the shift in focus from traditional medical care to addressing crucial factors like housing, food, transportation, and utilities for positive health outcomes.
Dr Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors
January 4th 2024Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).
Dr Elaine Siegfried Describes How AAD Guideline Update Impacts AD Treatment
January 1st 2024Elaine Siegfried, MD, of Saint Louis University School of Medicine, discusses how the recent guideline update by the American Academy of Dermatology (AAD) affects dermatologists' atopic dermatitis (AD) treatment decisions.
Delayed PAH Diagnosis Increased Economic Burden, Study Says
December 19th 2023Increased pulmonary arterial hypertension (PAH) awareness and earlier screening in routine clinical practice could provide an opportunity for earlier treatment, resulting in reduced economic burden for payers, employers, and society at large.